Login
Sign Up
Discover
Following
News
Stocks
Notification
Profile
Bookmarks
Chats
History
Creator Center
Copy Trading
Live
Settings
Post
Post
Annie所长
--
Content verified, no material discrepancies in the post
中国国家药监局批准了礼来的口服减肥药。
$LLYB
盘前涨3%创新高,
$NVO
跟涨1%。
这是中国首个获批的口服GLP-1减肥药。中国是全球第二大医药市场,肥胖人群规模全球第一梯队,超重、肥胖成年人5亿。
这是块大肉啊!预计每年能贡献10-140亿美元营收。
NVO
-1.95%
LLYB
+0.21%
1
571
Join global crypto users on Binance Square
⚡️ Get latest and useful information about crypto.
💬 Trusted by the world’s largest crypto exchange.
👍 Discover real insights from verified creators.
Email / Phone number
Sign up to earn rewards
Login
Sitemap
Cookie Preferences
Platform T&Cs